Abstract
As antioxidants play a protective role in the pathophysiology of diabetes and cardiovascular diseases, understanding the physiological status of antioxidant concentration among people at high risk for developing these conditions, such as Metabolic Syndrome, is of interest. In present study out of 187 first degree non-diabetic relatives and 192 non-diabetic spouses, 33.1% and 19.7% were found to have metabolic syndrome respectively. Subjects with metabolic syndrome (≥3 risk factors) had poor antioxidants status as reflected by significantly low levels of vitamin A, C & E and significantly increased (p<0.01) oxidative stress as compared to those without metabolic syndrome. At the same time serum insulin levels and insulin resistance were found to be significantly high (p<0.001) in metabolic syndrome. A strong positive correlation (r=0.946; p<0.001) between oxidative stress and insulin resistance was observed in metabolic syndrome. Low levels of antioxidants and increased oxidative stress with insulin resistance in metabolic syndrome suggests that besides therapeutic life style changes (TLC) as suggested in ATP III guidelines inclusion of antioxidant vitamins, fruits and vegetable could be beneficial to ward off the consequences of metabolic syndrome.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Oberly, L.W. (1988) Free radicals and diabetes. Free Rad. Biol. Med. 5, 113–124.
Halliwell, B. (1997) Antioxidants and human disease: a general introduction. Nutrition Reviews 55, S44–52.
Diaz, M.N., Frei, B., Vita, J.A., Keaney, J.F. (1997) Antioxidants and Atherosclerotic Heart Disease. The New Eng. Jour. Med. 7, 408–16.
Light, D.W., Carrier, M.J., Anggard, E.E. (2000) Antioxidants, diabetes and endothelial dysfunction. Cardiovasc. Res. 47, 457–464.
Asplund, K. (2002) Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J. Intern. Med. 251, 372–392.
Isomaa, B., Almgren, P., Tuomi, T., Foren, B., Lahti, K., Nissen, M., Taskinen, M.R., Groop, L. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 24, 683–689.
Wilson, P.W., Kannel, W.B., Silbershatz, H., D’Agostino, R.B. (1999) Clustering of metabolic factors and coronary heart disease. Arch. Intern. Med. 159, 1104–1109.
Lakka, H.M., Laaksonen, D.E., Lakka, T.A., Niskanen, L.K., Kumpusalo, E., Tuomilehto, J., Salonen, J.T. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288, 2709–2716.
Meigs, J.B. (2002) Epidemiology of the metabolic syndrome. Am J. Manag. Care. 8 (Suppl.), S283-S292.
National Institutes of Health (2001): Executive Summary. In Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (19), 2486–2497
Elbein, S.C., Maxwell, T.M., Schumacher, M.C. (1991) Insulin and glucose levels and prevalence of glucose intolerance in pedigrees with multiple diabetic siblings. Diabetes 40, 1024–1032
Mayer, E.J., Newman, B., Austin, M.A., Zhang, D., Quesenberry, C.P., Edwards, K., Selby, J.V. (1996) Genetic and environmental influences on insulin levels and the insulin resistance syndrome: an analysis of women twins. Am. J. Epidemiol. 143, 323–332.
Natelson, S., Thomas, C.C. (1971) In techniques of Clinical Chemistry 3rd ed., Publisher Springfield Illinois: 751–755
Natelson, S., Thomas, C.C. (1971) In techniques of Clinical Chemistry 3rd ed., Publisher Springfield Illinois: 162–165
Fabianek, J., DeFilippi, J., Rickards, T. and Herp, A. (1968). Micromethod for tocopherol determination in blood serum. Clin. Chem. 14, 456–62
Ohkawa, H., Ohishi, N. and Yagi, K. (1979) Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Annal. Biochem. 95, 351–353.
Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.L. (1985) Homeostasis model assessment; Insulin resistance and â cell function from fasting plasma glucose and insulin concentration in man, Diabetologia 28, 412–419.
Bierman, E.L. (1992) George Lyman Duff Memorial Lecture: Atherogenesis in diabetes. Arterioscler. Thromb. 12, 647–656.
Keaney, J.F. and Loscalzo, J. (1999) Diabetes, Oxidative Stress, and Platelet Activation. Circulation 99, 189–191.
Esterbaur, H., Gebicki, J., Puhl, H., Jurgens, G. (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free. Rad. Biol. Med. 13, 341–391.
Ford, S.E., Mokdad, A.H., Giles, W.H. and Brown, D.W. (2003) The Metabolic syndrome and antioxidant concentrations. Diabetes 52, 2346–2352.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sharma, P., Mishra, S., Ajmera, P. et al. Oxidative stress in metabolic syndrome. Indian J Clin Biochem 20, 145–149 (2005). https://doi.org/10.1007/BF02893061
Issue Date:
DOI: https://doi.org/10.1007/BF02893061